• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体向血液方向的眼部药物的视网膜脉络膜巩膜通透性:定量评估。

Retina-choroid-sclera permeability for ophthalmic drugs in the vitreous to blood direction: quantitative assessment.

机构信息

Department of Chemical and Petroleum Engineering, Sharif University of Technology, Tehran, Iran.

出版信息

Pharm Res. 2013 Jan;30(1):41-59. doi: 10.1007/s11095-012-0847-9. Epub 2012 Oct 2.

DOI:10.1007/s11095-012-0847-9
PMID:23054085
Abstract

PURPOSE

To determine the outward permeability of retina-choroid-sclera (RCS) layer for different ophthalmic drugs and to develop correlations between drug physicochemical properties and RCS permeability.

METHODS

A finite volume model was developed to simulate pharmacokinetics in the eye following drug administration by intravitreal injection. The RCS permeability was determined for 32 compounds by best fitting the drug concentration-time profile obtained by simulation with previously reported experimental data. Multiple linear regression was then used to develop correlations between best fit RCS permeability and drugs physicochemical properties.

RESULTS

The RCS drug permeabilities had values that ranged over 3 × 10(-6) m/s. Regression analysis for hydrophilic compounds showed that more than 92% of the variation in permeability values can be explained by correlative models of drug properties that include logarithm of the octanol-water partition coefficient (LogP), protein binding (PB), number of hydrogen bond acceptors (HBA), hydrogen bond donors (HBD), polar surface area (PSA) and dissociation constant (pKa) as independent variables. Regression analysis for lipophilic compounds showed that no significant correlation can be found between just physicochemical properties and RCS permeability.

CONCLUSION

Using the RCS permeability obtained from this study for different drugs, one can predict pharmacokinetics of intravitreal drug delivery systems such as solid implants or colloidal systems. Furthermore, the developed correlations between RCS permeability and physicochemical properties of drugs are useful in early drug development by predicting RCS permeability and drug concentration in the vitreous without experimental data.

摘要

目的

确定视网膜脉络膜巩膜(RCS)层对不同眼科药物的外向渗透性,并建立药物物理化学性质与 RCS 渗透性之间的相关性。

方法

开发了一个有限体积模型,以模拟通过玻璃体内注射给药后眼睛内的药代动力学。通过将模拟获得的药物浓度-时间曲线与先前报道的实验数据最佳拟合,确定了 32 种化合物的 RCS 渗透性。然后,使用多元线性回归建立最佳拟合 RCS 渗透性与药物物理化学性质之间的相关性。

结果

RCS 药物渗透性的值范围在 3×10(-6) m/s 之间。亲水化合物的回归分析表明,渗透率值的变化超过 92%可以用包括药物性质的相关模型来解释,这些模型包括辛醇-水分配系数(LogP)的对数、蛋白结合(PB)、氢键受体(HBA)的数量、氢键供体(HBD)、极性表面积(PSA)和离解常数(pKa)作为独立变量。亲脂性化合物的回归分析表明,仅仅通过物理化学性质与 RCS 渗透性之间没有显著的相关性。

结论

使用本研究中获得的不同药物的 RCS 渗透性,可以预测玻璃体内药物输送系统(如固体植入物或胶体系统)的药代动力学。此外,所建立的药物 RCS 渗透性与物理化学性质之间的相关性对于早期药物开发非常有用,可以在没有实验数据的情况下预测 RCS 渗透性和玻璃体内的药物浓度。

相似文献

1
Retina-choroid-sclera permeability for ophthalmic drugs in the vitreous to blood direction: quantitative assessment.玻璃体向血液方向的眼部药物的视网膜脉络膜巩膜通透性:定量评估。
Pharm Res. 2013 Jan;30(1):41-59. doi: 10.1007/s11095-012-0847-9. Epub 2012 Oct 2.
2
Pharmacokinetic model for in vivo/in vitro correlation of intravitreal drug delivery.玻璃体内药物递送体内/体外相关性的药代动力学模型。
Adv Drug Deliv Rev. 2001 Oct 31;52(1):17-24. doi: 10.1016/s0169-409x(01)00187-9.
3
Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.经巩膜给药至眼后段:药代动力学建模的前景
Adv Drug Deliv Rev. 2006 Nov 15;58(11):1164-81. doi: 10.1016/j.addr.2006.07.025. Epub 2006 Sep 16.
4
Evaluation of an ex vivo model implication for carrier-mediated retinal drug delivery.用于载体介导的视网膜药物递送的离体模型意义评估。
Curr Eye Res. 2006 May;31(5):415-26. doi: 10.1080/02713680600646890.
5
Permeability of the Retina and RPE-Choroid-Sclera to Three Ophthalmic Drugs and the Associated Factors.视网膜及视网膜色素上皮-脉络膜-巩膜对三种眼科药物的通透性及相关因素
Pharmaceutics. 2021 May 4;13(5):655. doi: 10.3390/pharmaceutics13050655.
6
In silico model of drug permeability across sublingual mucosa.经舌下黏膜药物渗透的计算模型。
Arch Oral Biol. 2013 May;58(5):545-51. doi: 10.1016/j.archoralbio.2012.09.020. Epub 2012 Nov 1.
7
Role of retinal pigment epithelium permeability in drug transfer between posterior eye segment and systemic blood circulation.视网膜色素上皮通透性在后节眼与全身血液循环药物转运中的作用。
Eur J Pharm Biopharm. 2019 Oct;143:18-23. doi: 10.1016/j.ejpb.2019.08.008. Epub 2019 Aug 13.
8
Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes.兔眼经球后注射用荧光光度法测定眼内注射俄勒冈绿488标记曲安奈德的药代动力学
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4506-14. doi: 10.1167/iovs.08-1989. Epub 2008 May 23.
9
In vivo/in vitro correlation of intravitreal delivery of drugs with the help of computer simulation.借助计算机模拟对玻璃体内给药进行体内/体外相关性研究。
Biol Pharm Bull. 1994 Feb;17(2):283-90. doi: 10.1248/bpb.17.283.
10
Effect of benzalkonium chloride on transscleral drug delivery.苯扎氯铵对经巩膜给药的影响。
Invest Ophthalmol Vis Sci. 2005 Feb;46(2):703-8. doi: 10.1167/iovs.03-0934.

引用本文的文献

1
Human nerve growth factor delivery to the retina: Quantitative methodology and mathematical modeling in preclinical settings.人神经生长因子向视网膜的递送:临床前环境中的定量方法和数学建模
PNAS Nexus. 2025 Aug 11;4(8):pgaf250. doi: 10.1093/pnasnexus/pgaf250. eCollection 2025 Aug.
2
Effect of Combination Use of Aqueous Humor Secretion Inhibitor Eye Drops on Aflibercept Level: A Preliminary Analysis.房水分泌抑制剂滴眼液联合使用对阿柏西普水平的影响:初步分析
Transl Vis Sci Technol. 2025 Feb 3;14(2):21. doi: 10.1167/tvst.14.2.21.
3
Experimental and mathematical approaches for drug delivery for the treatment of wet age-related macular degeneration.

本文引用的文献

1
Simulating dissolution of intravitreal triamcinolone acetonide suspensions in an anatomically accurate rabbit eye model.模拟曲安奈德混悬液在解剖精确的兔眼模型中的溶解。
Pharm Res. 2010 Aug;27(8):1530-46. doi: 10.1007/s11095-010-0163-1. Epub 2010 May 14.
2
In vitro transport and partitioning of AL-4940, active metabolite of angiostatic agent anecortave acetate, in ocular tissues of the posterior segment.在体后部眼部组织中血管生成抑制剂安柯瑞醋酸盐的活性代谢产物 AL-4940 的转运和分配。
J Ocul Pharmacol Ther. 2010 Apr;26(2):137-46. doi: 10.1089/jop.2009.0132.
3
Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure-pharmacokinetic relationships (QSPKR).
用于治疗湿性年龄相关性黄斑变性的药物输送的实验和数学方法。
J Control Release. 2023 Nov;363:464-483. doi: 10.1016/j.jconrel.2023.09.021. Epub 2023 Oct 4.
4
Effects of Flow Hydrodynamics and Eye Movements on Intraocular Drug Clearance.流体动力学和眼球运动对眼内药物清除率的影响。
Pharmaceutics. 2022 Jun 15;14(6):1267. doi: 10.3390/pharmaceutics14061267.
5
Lipid Nanoparticles for the Posterior Eye Segment.用于眼后节的脂质纳米颗粒。
Pharmaceutics. 2021 Dec 31;14(1):90. doi: 10.3390/pharmaceutics14010090.
6
Permeability of the Retina and RPE-Choroid-Sclera to Three Ophthalmic Drugs and the Associated Factors.视网膜及视网膜色素上皮-脉络膜-巩膜对三种眼科药物的通透性及相关因素
Pharmaceutics. 2021 May 4;13(5):655. doi: 10.3390/pharmaceutics13050655.
7
Extended Pharmacokinetic Model of the Intravitreal Injections of Macromolecules in Rabbits. Part 2: Parameter Estimation Based on Concentration Dynamics in the Vitreous, Retina, and Aqueous Humor.兔眼玻璃体内注射大分子药物的扩展药代动力学模型。第2部分:基于玻璃体、视网膜和房水中药物浓度动态变化的参数估计。
Pharm Res. 2020 Oct 22;37(11):226. doi: 10.1007/s11095-020-02946-1.
8
Targeted Drug Delivery Systems for the Treatment of Glaucoma: Most Advanced Systems Review.用于治疗青光眼的靶向给药系统:最先进系统综述
Polymers (Basel). 2019 Oct 24;11(11):1742. doi: 10.3390/polym11111742.
9
Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection.三维玻璃体腔和脉络膜下腔药物注射输送模型。
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5266-5276. doi: 10.1167/iovs.17-23632.
10
Extended Pharmacokinetic Model of the Rabbit Eye for Intravitreal and Intracameral Injections of Macromolecules: Quantitative Analysis of Anterior and Posterior Elimination Pathways.兔眼玻璃体内和前房内注射大分子的扩展药代动力学模型:前、后消除途径的定量分析。
Pharm Res. 2018 May 31;35(8):153. doi: 10.1007/s11095-018-2435-0.
基于药物理化性质预测玻璃体内半衰期:定量构效关系(QSPKR)。
Pharm Res. 2009 May;26(5):1236-60. doi: 10.1007/s11095-008-9728-7. Epub 2008 Oct 8.
4
Computer modeling of drug delivery to the posterior eye: effect of active transport and loss to choroidal blood flow.药物向后部眼部递送的计算机模拟:主动转运及脉络膜血流损失的影响
Pharm Res. 2008 Nov;25(11):2685-96. doi: 10.1007/s11095-008-9691-3. Epub 2008 Aug 5.
5
Functional activity of a large neutral amino acid transporter (LAT) in rabbit retina: a study involving the in vivo retinal uptake and vitreal pharmacokinetics of L-phenyl alanine.兔视网膜中大型中性氨基酸转运体(LAT)的功能活性:一项涉及L-苯丙氨酸体内视网膜摄取和玻璃体液药代动力学的研究。
Int J Pharm. 2008 Jan 22;347(1-2):23-30. doi: 10.1016/j.ijpharm.2007.06.038. Epub 2007 Jun 29.
6
Clearance of intravitreal voriconazole.玻璃体内伏立康唑的清除率。
Invest Ophthalmol Vis Sci. 2007 May;48(5):2238-41. doi: 10.1167/iovs.06-1362.
7
Topical and systemic drug delivery to the posterior segments.向眼后段的局部和全身给药。
Adv Drug Deliv Rev. 2005 Dec 13;57(14):2010-32. doi: 10.1016/j.addr.2005.09.004. Epub 2005 Nov 10.
8
The pharmacokinetics of rituximab following an intravitreal injection.玻璃体内注射后利妥昔单抗的药代动力学。
Exp Eye Res. 2006 May;82(5):760-6. doi: 10.1016/j.exer.2005.09.018. Epub 2005 Nov 11.
9
Cell culture models of the ocular barriers.眼部屏障的细胞培养模型。
Eur J Pharm Biopharm. 2005 Jul;60(2):207-25. doi: 10.1016/j.ejpb.2005.01.009.
10
Intraocular properties of urokinase-derived antiangiogenic A6 peptide in rabbits.尿激酶衍生的抗血管生成A6肽在兔眼内的特性
J Ocul Pharmacol Ther. 2004 Oct;20(5):439-49. doi: 10.1089/jop.2004.20.439.